HL231

HL231 · Haisco Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HL231, covering 2024-10-16 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients With COPD [Phase 3]